Cleared Special

K230382 - 3 Series NeoLux (FDA 510(k) Clearance)

Mar 2023
Decision
39d
Days
Class 2
Risk

K230382 is an FDA 510(k) clearance for the 3 Series NeoLux. This device is classified as a Light, Ultraviolet, Dermatological (Class II - Special Controls, product code FTC).

Submitted by Daavlin Distributing Co. (Bryan, US). The FDA issued a Cleared decision on March 24, 2023, 39 days after receiving the submission on February 13, 2023.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4630.

Submission Details

510(k) Number K230382 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 13, 2023
Decision Date March 24, 2023
Days to Decision 39 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code FTC - Light, Ultraviolet, Dermatological
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4630